Heritage Pharmaceuticals Inc recalls Desipramine Hydrochloride Tablets, USP, 25 mg, 100 count bottle (NDC 23155-579-01), Rx only, Manufactured by: USV Private Limited,…

CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.

Date

2025-11-05

Country

United States

Brand

Heritage Pharmaceuticals

Product

Desipramine Hydrochloride Tablets, USP, 25 mg, 100 count bottle (NDC 23155-579-01), Rx only, Manufactured by: USV Private Limited, Daman,…

Classification

Class II

Units

U.S. Nationwide.

Category

Drugs & medical

Source

FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Heritage Pharmaceuticals recalls

1. 2026-08-19
2. US
   Drugs & medicalClass II

   Heritage Pharmaceuticals Inc recalls CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc.,…

   Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.

   FDA · DrugHeritage Pharmaceuticals IncNationwide within the U.SOfficial notice →
3. 2022-12-07
4. US
   Drugs & medicalClass II

   Heritage Pharmaceuticals Inc recalls Desmopressin Acetate Tablets 0.2mg, 100-count bottles, RX Only, Distributed by: Avet Pharmaceuticals Inc. East Brunswick, NJ 08816,…

   Subpotent Drug

   FDA · DrugHeritage Pharmaceuticals IncNationwide within the United StatesOfficial notice →

Other drugs & medical recalls in the United States

1. 2025-11-05
2. US
   Drugs & medicalClass II

   Kenvue Brands LLC recalls TYLENOL, Acetaminophen, Extra Strength, 24 Caplets, 500mg each, distributed by: Johnson & Johnson Consumer Inc., McNeil Consumer…

   Defective Container

   FDA · DrugKenvue Brands LLCU.S. Nationwide - CO, IL, OH and IN.Official notice →
3. US
   Drugs & medicalClass II

   ProRx LLC recalls Semaglutide Injection, 10 mg/4 mL (2.5 mg/mL), 4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton,…

   Lack of Assurance of Sterility

   FDA · DrugProRx LLCTX and UTOfficial notice →
4. US
   Drugs & medicalClass II

   QuVa Pharma, Inc. recalls R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sodium Chloride Solution, Total Volume: 50 mL…

   Presence of Particulate Matter

   FDA · DrugQuVa Pharma, Inc.U.S. NationwideOfficial notice →
5. US
   Drugs & medicalClass II

   Teva Pharmaceuticals USA, Inc recalls Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, a) 100…

   CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.

   FDA · DrugTeva Pharmaceuticals USA, IncU.S. NationwideOfficial notice →
6. US
   Drugs & medicalClass II

   Amerisource Health Services LLC recalls Prazosin Hydrochloride, Capsules, USP, 5 mg, 20 capsules (5x4) cartons, Rx only, Distributed by American Health Packaging,…

   Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit

   FDA · DrugAmerisource Health Services LLCNationwide within the United StatesOfficial notice →
7. US
   Drugs & medicalClass II

   Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release Capsules, USP, 60 mg, a.) 90-count bottle (NDC: 51991-748-90), b.)1000-count bottle (NDC…

   CGMP Deviations: N-nitroso-duloxetine impurity above the safety assessment limit of 12.5ppm.

   FDA · DrugBreckenridge Pharmaceutical, Inc.U.S. NationwideOfficial notice →